MDxHealth SA (MDXH) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN BE0974461940
MDxHealth SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 90.05 m USD | 107.88 m USD |
| Gross profit | 55.14 m USD | 64.44 m USD |
| Operating income | -24.72 m USD | -15.40 m USD |
| EBIT | -30.06 m USD | -23.22 m USD |
| Net income | -38.07 m USD | -33.52 m USD |
| Diluted EPS – continuing operations | -0.78 USD | -0.67 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
More stocks
- Bionano Genomics, Inc. (BNGO)
- SunPower Inc. (SPWR)
- KYNTRA BIO, INC. (KYNB)
- Inhibitor Therapeutics, Inc. (INTI)
- Neuphoria Therapeutics Inc. (NEUP)
- KEEMO Fashion Group Ltd (KMFG)
- Virtuix Holdings Inc. (VTIX)
- Good Times Restaurants Inc. (GTIM)
- Linkhome Holdings Inc. (LHAI)
- Foreveren (FOR.WA)
- SYNLOGIC, INC. (SYBX)
- Greenpro Capital Corp. (GRNQ)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.